The board of directors of Innovent Biologics, Inc. announced that Mr. Shuyun Chen (Mr. Chen) has tendered his resignation as a non-executive Director to dedicate time to his other professional commitments, with effect from February 25, 2022. Upon Mr. Chen's resignation, Mr. Chen also resigned from
his role as member of the audit committee of the Board and the strategy committee of the Board. In the meantime, Dr. Charles Leland Cooney, an independent non-executive Director, will act as a member of the Audit Committee, with effect from February 25, 2022.